探讨脓毒症的病因病机及治疗方法。
This paper discusses the causes, pathogenesis and treatment methods of sepsis.
脓毒症的研究进展和内皮细胞微粒密切相关。
Endothelial microparticles are closely related to the advances of research of sepsis.
最初界定蛋白是监测脓毒症的动物模型中的干细胞。
Initial identification of the proteins to monitor generally stems from animal models of sepsis.
目的探讨静脉导管相关性栖稻黄单胞菌脓毒症的临床特点。
Objective To investigate the clinical features of venous catheter associated Flavimonas oryzihabitans sepsis.
目的：在脓毒症的治疗中，治疗及预防高血糖是指南意见之一。
Objective: Treatment and prevention of hyperglycemia has been advocated for subjects with sepsis.
目的探讨连续血液净化(CBP)治疗严重脓毒症的疗效及免疫调节机制。
Objective to investigate the efficacy of continuous blood purification (CBP) in the treatment of severe sepsis, and explore the related immune regulatory mechanisms.
此外，大面积深度烧伤合并吸入性损伤易并发肺部感染，成为脓毒症的诱因。
Severe burn patients with inhalation injury were much more susceptible to pulmonary infection forming one of the causative factors of sepsis.
上述结果为临床脓毒症的预后判断和疗效评估提供了新的实验证据和研究思路。
These results provided new experimental evidences and research ideas for the prognosis prediction and efficacy evaluation of therapies in sepsis.
PCR方法检测血中细菌DNA能准确反映肠道细菌移位并预告感染和脓毒症的发生。
Detection of blood microbial DNA using PCR could reflect bacteria translocation and forecast imminent infection and sepsis.
尽管当今生物技术和医学监护手段飞速发展，但脓毒症的临床患病率和死亡率仍居高不下。
Although biotechnology and medical care have been rapidly developing, the prevalence and death rate of clinical sepsis remain high.
而且目前对脓毒症的认知性差，对脓毒症治疗指南的依从性低，严重影响着脓毒症的早期诊断。
Now the recognition to sepsis is deficiency, the compliance to sepsis treatment guide is low, so both of them affect the early diagnosis of sepsis greatly.
结论腹部外科脓毒症治疗困难，死亡率高，采用综合救治新对策能降低腹部外科脓毒症的死亡率。
Conclusion it was difficult to treat sepsis patients induced by severe abdominal infection and our new multiple treatment could significantly reduce the mortality of severe sepsis.
此外，经过丈量烧伤创面脓毒症的临床病症和体征，诊断是艰难的最好是由串行伤口认真的评价。
Furthermore, gauging burn wound sepsis by clinical signs and symptoms is difficult and diagnosis is best made by careful serial evaluations of the wound.
尽管针对脓毒症抗凝治疗的临床研究尚存在争议，但并不能因此而全面否定抗凝治疗对脓毒症的价值。
Although there is controversy about the clinical trials on the anticoagulation therapy for sepsis, the clinical value of anticoagulation therapy can not be completely denied.
目前所采用的一些指标确实有助于严重脓毒症的诊断，但是，我们需要更特异的指标来指导临床工作。
There are defects for these parameters although they are useful to some extent in diagnosing severe sepsis. We need more specific indexes to diagnose severe sepsis.
摘要：目的：分析我院儿童严重脓毒症的病原菌分布及其耐药情况，为临床合理使用抗菌药物提供依据。
ABSTRACT: OBJECTIVE: to analyze bacteria distribution and drug resistance of pediatric severe sepsis in our hospital, and to provide reference for clinical rational use of antimicrobial agents.
脓毒症是一种发病急、病情进展迅速、病死率高的危重疾病，长期以来脓毒症的本质及概念一直混淆不清。
Sepsis is an urgent, rapid-developing critical disease with a high mortality. The essence and concept of sepsis have been confused for a long time.
近年来出现了一些血液净化治疗新技术，但其治疗烧伤脓毒症的安全性和有效性仍缺乏大样本的临床验证。
In recent years, a few new CBP technologies were applied in the clinic, however, there were few large scale investigations on their safety and efficacy.
所以文中将这些零碎的文献分布于几个部分进行介绍，即脓毒症的定义、诊断标准、发病机制和治疗进展。
We introduce these fragmentary documents in several phases: the definition of Sepsis, the standard of diagnoses, the cause of Sepsis and the evolution of therapy.
近年来，随着科学家对脓毒症的深入研究，发现其病程变化中免疫系统的功能障碍是脓毒症中的一个突出问题。
It is the leading cause of death in critically ill patients. In recent years, scientists 'in-depth study of sepsis found that dysfunction is a prominent issue in the pathophysiology of sepsis.
结论CBP是治疗严重脓毒症的有效措施之一，能改善其凝血功能，而改善凝血功能的机制可能与多种因素有关。
Conclusion CBP is one of effective methods for the patients with severe sepsis, and can improve the coagulation function of these patients.
相反，弥散性微血管内血栓形成是脓毒症相关多器官功能障碍的重要发病机制，为脓毒症的抗凝治疗提供了充足的理论基础。
In contrast, disseminated intravascular thrombosis is an important pathogenesis of sepsis related multiple organ dysfunction, which provides a theoretical basis for the anticoagulation therapy.
此时中医治疗显示出重要作用，故第二篇简要介绍近十年来国内应用中医手段治疗脓毒症的研究成果，而主要是从中医药的现代药理学机制方面阐述的。
At this time, Chinese Medicine has hold on an important role, so the second part briefly introduces the most recent ten years' development through Chinese Medicine treatment.
与脓毒症相关的蛋白质分子有很多。
The catalog of proteic molecules associated with sepsis is extensive.
研究人员使用一些动物和人类脓毒症模型，通过一系列的试验来确认脓毒症与VEGF水平之间存在关联。
Using several animal and human models of the disease, the authors performed a series of experiments to confirm the association between sepsis and circulating levels of VEGF.
急性肾功能衰竭患者可能需要最多60天的透析治疗，除非存在脓毒症，否则患者有希望恢复正常的肾功能。
Patients with acute renal failure may require up to 60 days of dialysis treatment; unless sepsis is present, patients are likely to regain normal kidney function.
HMGB1 -CD 24 -Siglec系统能限制更严重的无菌性炎症反应，如脓毒症吗？
Can the HMGB1-CD24-Siglec system limit the more severe forms of sterile inflammation, such as sepsis?
目的探讨巨噬细胞移动抑制因子在脓毒症小鼠心脏和肾组织中的表达规律。
Objective to investigate the expression profile of macrophage inhibitory factor in heart and renal tissues of sepsis mice.
血必净注射液对脓毒症具有较好的治疗作用，其机制与甲泼尼龙的抗炎作用类似。
Xuebijing injection and methylprednisolone are effective in the treatment of sepsis, and they have the similar clinical effect.
结论长托宁通过抑制肺血管内皮细胞ICAM - 1的表达，对大鼠脓毒症肺损伤具有保护作用。
Conclusion PQN inhibits the expression of ICAM-1 in lung vascular endothelium, and had protective effects on acute lung injury induced by sepsis.
应用推荐